FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Karel Waisser

Research Profile

Chemicals & Drugs

Procedures

Living Beings

Concepts & Ideas

Occupations

Phenomena

Co-author Network

Publications

TOP 3
Karel Waisser; Jiří Kuneš; Eva Novotná; Jiřina Solaříková
Phenyl salicylates - a new group of potential antituberculotics.
Karel Waisser
[Where does the development of new antituberculotics aim at?].
Karel Waisser; Jozef Cizmárik
[Derivatives of phenylcarbamic acid as potential antituberculotics].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Karel Waisser (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Karel Waisser; Jiří Kuneš; Eva Novotná; Jiřina Solaříková
Phenyl salicylates - a new group of potential antituberculotics.
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti 2012;61(6):282-4.
2012: Karel Waisser
[Where does the development of new antituberculotics aim at?].
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti 2012;61(4):150-8.
2012: Karel Waisser; Jozef Cizmárik
[Derivatives of phenylcarbamic acid as potential antituberculotics].
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti 2012;61(1-2):17-20.
2011: E Petrlíková; Karel Waisser; L Heinisch; J Stolaříková
New S-benzylisothiosemicarbazones with antimycobacterial activity.
Folia microbiologica 2011;56(1):10-2.
2010: Eva Petrlíková; Karel Waisser; Hana Divišová; Petra Husáková; Petra Vrabcová; Jiří Kuneš; Karel Kolář; Jiřina Stolaříková
Highly active antimycobacterial derivatives of benzoxazine.
Bioorganic & medicinal chemistry 2010;18(23):8178-87.
2010: E Petrlíková; Karel Waisser; Petr Jílek; I Dufková
Antibacterial activity of N-benzylsalicylthioamides.
Folia microbiologica 2010;55(5):418-21.
2010: Eva Petrlíková; Karel Waisser; Vladimír Buchta; Petr Jílek; Marcela Vejsová
N-Benzylsalicylthioamides as novel compounds with promising antimycotic activity.
Bioorganic & medicinal chemistry letters 2010;20(15):4535-8.
2010: Karel Waisser; Eva Petrlíková; Milan Perina; Vera Klimesová; Jirí Kunes; Karel Palát; Jarmila Kaustová; Hans-Martin Dahse; Ute Möllmann
A note to the biological activity of benzoxazine derivatives containing the thioxo group.
European journal of medicinal chemistry 2010;45(7):2719-25.
2009: Vera Klimesová; Jan Kocí; Karel Waisser; Jarmila Kaustová; Ute Möllmann
Preparation and in vitro evaluation of benzylsulfanyl benzoxazole derivatives as potential antituberculosis agents.
European journal of medicinal chemistry 2009;44(5):2286-93.
2009: Rafael Dolezal; Karel Waisser; Eva Petrlíková; Jirí Kunes; Lenka Kubicová; Milos Machacek; Jarmila Kaustová; Hans-Martin Dahse
N-benzylsalicylthioamides: highly active potential antituberculotics.
Archiv der Pharmazie 2009;342(2):113-9.
2008: Karel Waisser; Josef Matyk; Jirí Kunes; Rafael Dolezal; Jarmila Kaustová; Hans-Martin Dahse
Highly active potential antituberculotics: 3-(4-alkylphenyl)-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 3-(4-alkylphenyl)-2H-1,3-benzoxazine-2,4(3H)-dihiones substituted in ring-B by halogen.
Archiv der Pharmazie 2008;341(12):800-3.
2007: Karel Waisser; Josef Matyk; Hana Divisová; Petra Husáková; Jirí Kunes; Vera Klimesová; Karel Palát; Jarmila Kaustová
The oriented development of antituberculotics (Part II): halogenated 3-(4-alkylphenyl)-1,3-benzoxazine-2,4-(3H)-diones.
Archiv der Pharmazie 2007;340(5):264-7.
2007: Jan Adamec; Rainer Beckert; Dieter Weiss; Vera Klimesová; Karel Waisser; Ute Möllmann; Jarmila Kaustová; Vladimír Buchta
Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activities.
Bioorganic & medicinal chemistry 2007;15(8):2898-906.
2006: Andrey Toropov; Karel Nesmerak; Ivan Raska; Karel Waisser; Karel Palat
QSPR modeling of the half-wave potentials of benzoxazines by optimal descriptors calculated with the SMILES.
Computational biology and chemistry 2006;30(6):434-7.
2006: Karel Waisser; Josef Matyk; Hana Divisová; Petra Husáková; Jirí Kunes; Vera Klimesová; Jarmila Kaustová; Ute Möllmann; Hans-Martin Dahse; Milan Miko
The oriented development of antituberculotics: salicylanilides.
Archiv der Pharmazie 2006;339(11):616-20.
2006: Karel Waisser; L Heinisch; M Slosárek; J Janota
New antimycobacterial 2,3-dihydro-1-alkylindole-2-thiones.
Folia microbiologica 2006;51(1):25-6.
2006: Karel Waisser; R Dolezal; Karel Palát; J Cizmárik; Jarmila Kaustová
QSAR study of antimycobacterial activity of quaternary ammonium salts of piperidinylethyl esters of alkoxysubstituted phenylcarbamic acids.
Folia microbiologica 2006;51(1):21-4.
2005: Jan Adamec; Karel Waisser; Jirí Kunes; Jarmila Kaustová
A note on the antitubercular activities of 1-aryl-5-benzylsulfanyltetrazoles.
Archiv der Pharmazie 2005;338(8):385-9.
2005: Josef Matyk; Karel Waisser; Katerina Drazková; Jirí Kunes; Vera Klimesová; Karel Palát; Jarmila Kaustová
Heterocyclic isosters of antimycobacterial salicylanilides.
Farmaco (Società chimica italiana : 1989) 2005;60(5):399-408.
2005: Karel Waisser; L Heinisch; M Slosárek; J Janota
New antimycobacterial S-alkylisothiosemicarbazones.
Folia microbiologica 2005;50(6):479-81.
2005: Karel Waisser; Jan Adamec; R Dolezal; Jarmila Kaustová
1-Aryl-5-benzylsulfanyltetrazoles, a new group of antimycobacterial compounds against potentially pathogenic strains.
Folia microbiologica 2005;50(3):195-7.
2004: Lenka Zahajská; Vera Klimesová; Jan Kocí; Karel Waisser; Jarmila Kaustová
Synthesis and antimycobacterial activity of pyridylmethylsulfanyl and naphthylmethylsulfanyl derivatives of benzazoles, 1, 2, 4-triazole, and pyridine-2-carbothioamide/-2-carbonitrile.
Archiv der Pharmazie 2004;337(10):549-55.
2004: Karel Waisser; Katerina Drazková; Jirí Kunes; Vera Klimesová; Jarmila Kaustová
Antimycobacterial N-pyridinylsalicylamides, isosters of salicylamides.
Farmaco (Società chimica italiana : 1989) 2004;59(8):615-25.
2004: Karel Waisser; Katerina Drazková
[Advances in the development of antitubercular agents containing no heterocyclic compounds in the pharmacophore. Part 2. Other derivatives except carboxylic acids].
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti 2004;53(3):124-30.
2004: Vera Klimesová; Lenka Zahajská; Karel Waisser; Jarmila Kaustová; Ute Möllmann
Synthesis and antimycobacterial activity of 1,2,4-triazole 3-benzylsulfanyl derivatives.
Farmaco (Società chimica italiana : 1989) 2004;59(4):279-88.
2004: Lenka Kubicová; M Sustr; Martin Pravda; Karel Waisser
Biological activity of 2-hydroxythiobenzanilides and related compounds.
Central European journal of public health 2004;12 Suppl():S57-9.
2004: Ana Gallegos; Ramon Carbó-Dorca; Robert Ponec; Karel Waisser
Similarity approach to QSAR. Application to antimycobacterial benzoxazines.
International journal of pharmaceutics 2004;269(1):51-60.
2004: Karel Waisser; Katerina Drazková; J Cizmárik; Jarmila Kaustová
A new group of potential antituberculotics: hydrochlorides of piperidinylalkyl esters of alkoxy-substituted phenylcarbamic acids.
Folia microbiologica 2004;49(3):265-8.
2003: Karel Waisser; Milan Perina; I Boudová; Jirí Kunes; Jarmila Kaustová
[A new group of potential antitubercular agents: antimycobacterial N-benzylsalicylamides].
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti 2003;52(6):291-4.
2003: Karel Waisser; Milan Perina; Jirí Kunes; Vera Klimesová; Jarmila Kaustová
3-Benzyl-2H-1,3-benzoxazine-2,4(3H)-diones, a new group of antimycobacterial compounds against potentially pathogenic strains.
Farmaco (Società chimica italiana : 1989) 2003;58(11):1137-49.
2003: Karel Waisser; Milan Pesina; Pavel Holý; Milan Pour; Otakar Bures; Jirí Kunes; Vera Klimesová; Vladimír Buchta; Petra Kubanová; Jarmila Kaustová
Antimycobacterial and antifungal isosters of salicylamides.
Archiv der Pharmazie 2003;336(6-7):322-35.
2003: Karel Waisser; Katerina Drazková
[Advances in the development of antitubercular agents containing no heterocyclics in the pharmacophore. Part 1. Derivatives of carboxylic acid].
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti 2003;52(2):73-81.
2003: Karel Waisser; Otakar Bures; Pavel Holý; Jirí Kunes; Radek Oswald; Lucie Jirásková; Milan Pour; Vera Klimesová; Lenka Kubicová; Jarmila Kaustová
Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
Archiv der Pharmazie 2003;336(1):53-71.
2003: Karel Waisser; Otakar Bures; Pavel Holý; Jirí Kunes; R Oswald; Lucie Jirásková; Milan Pour; Vera Klimesová; Karel Palát; Jarmila Kaustová; H M Danse; Ute Möllmann
Antimycobacterial 3-aryl-2H-1,3-benzoxazine-2,4(3H)-diones.
Die Pharmazie 2003;58(2):83-94.
2003: Karel Waisser; Katerina Drazková; J Cizmárik; Jarmila Kaustová
Antimycobacterial activity of piperidinylpropyl esters of alkoxy-substituted phenylcarbamic acids.
Folia microbiologica 2003;48(5):585-7.
2003: Petra Kubanová; Vladimír Buchta; Milan Perina; Karel Waisser; Milan Pour
Evaluation of in vitro antifungal activity of N-benzylsalicylamide derivatives.
Folia microbiologica 2003;48(3):346-50.
2003: Karel Waisser; Katerina Drazková; J Cizmárik; Jarmila Kaustová
Antimycobacterial activity of basic ethyl esters of alkoxy-substituted phenylcarbamic acids.
Folia microbiologica 2003;48(1):45-50.
2003: Karel Waisser; Pavel Holý; Otakar Bures; Jirí Kunes; Jarmila Kaustová
[New groups of potential antitubercular agents: 3-(4-ethoxythiocarbonylphenyl)-2-H-benzoxazin-2,4(3H)-diones and 3-(4-ethoxythiocarbonylphenyl)-4-thioxy-2H-benzoxazin-2(3H)-ones].
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti 2003;52(1):42-7.
2002: Jan Kocí; Vera Klimesová; Karel Waisser; Jarmila Kaustová; Hans-Martin Dahse; Ute Möllmann
Heterocyclic benzazole derivatives with antimycobacterial in vitro activity.
Bioorganic & medicinal chemistry letters 2002;12(22):3275-8.
2002: Jirí Kunes; Vojtech Balsánek; Milan Pour; Karel Waisser; Jarmila Kaustová
On the relationship between the substitution pattern of thiobenzanilides and their antimycobacterial activity.
Farmaco (Società chimica italiana : 1989) 2002;57(9):777-82.
2002: Karel Waisser; J Cizmárik; Katerina Drazková; Jarmila Kaustová
[Antimycobacterial effects of pyrrolidinoethylester alkoxysubstituted phenylcarbamic acids].
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti 2002;51(3):140-4.
2002: Vera Klimesová; Jan Kocí; Milan Pour; Jirí Stachel; Karel Waisser; Jarmila Kaustová
Synthesis and preliminary evaluation of benzimidazole derivatives as antimicrobial agents.
European journal of medicinal chemistry 2002;37(5):409-18.
2002: Vera Klimesová; Jan Kocí; Karel Waisser; Jarmila Kaustová
New benzimidazole derivatives as antimycobacterial agents.
Farmaco (Società chimica italiana : 1989) 2002;57(4):259-65.
2002: Karel Waisser; Lenka Kubicová; Vladimír Buchta; Petra Kubanová; K Bajerová; Lucie Jirásková; O Bednarík; Otakar Bures; Pavel Holý
In vitro antifungal activity of 3-phenyl-2H-benzoxazine-2,4(3H)-diones.
Folia microbiologica 2002;47(5):488-92.
2001: Karel Waisser; Otakar Bures; Pavel Holý
[Advances in the development of new antitubercular agents from orthocondensed heterocyclic compounds. Part 3. Substances containing several types of heteroatoms in the six-membered ring].
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti 2001;50(6):267-73.
2001: Karel Waisser; J Gregor; H Dostál; Jirí Kunes; Lenka Kubicová; Vera Klimesová; Jarmila Kaustová
Influence of the replacement of the oxo function with the thioxo group on the antimycobacterial activity of 3-aryl-6,8-dichloro-2H-1,3-benzoxazine-2,4(3H)-diones and 3-arylquinazoline-2,4(1H,3H)-diones.
Farmaco (Società chimica italiana : 1989) 2001;56(10):803-7.
2001: Karel Waisser; Otakar Bures; Pavel Holý
[Advances in the development of new antitubercular agents from a group of orthocondensed heterocyclic compounds. Part 2. Substances containing more nitrogen atoms in the 6-membered ring].
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti 2001;50(5):211-8.
2001: Karel Waisser; Otakar Bures; Pavel Holý
[Advances in the development of new antitubercular agents from a group of ortho-condensed heterocyclic compounds. Part 1. Compounds containing one heteroatom per six-membered ring].
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti 2001;50(4):159-65.
2001: Karel Waisser; J Gregor; Pavel Holý; Lenka Kubicová; Vera Klimesová; Jarmila Kaustová
[Antimicrobial salicylanilides and 3-phenyl-2H-1,3-benzoxazine-2,4(3H)-diones].
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti 2001;50(3):148-52.
2001: J Hladůvková; Karel Waisser; Jarmila Kaustová
[Development of chemotherapy in tuberculosis].
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti 2001;50(1):4-11.
2000: Karel Waisser; Pavel Holý; Otakar Bures
[Advances in the development of new antitubercular agents from a group of monocyclic 6-membered heterocyclic compounds with a greater number of nitrogen atoms].
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti 2000;49(6):268-77.
2000: Jirí Kunes; J Bazant; Milan Pour; Karel Waisser; M Slosárek; J Janota
Quinazoline derivatives with antitubercular activity.
Farmaco (Società chimica italiana : 1989) 2000;55(11-12):725-9.
2000: Jirí Kunes; Marcel Spulák; Karel Waisser; M Slosárek; J Janota
Quinoxaline derivatives as potential antituberculotic agents.
Die Pharmazie 2000;55(11):858-9.
2000: Vera Klimesová; Karel Palát; Karel Waisser; J Klimes
Combination of molecular modeling and quantitative structure-activity relationship analysis in the study of antimycobacterial activity of pyridine derivatives.
International journal of pharmaceutics 2000;207(1-2):1-6.
2000: Karel Waisser; Pavel Holý; Otakar Bures
[Advances in the development of new antitubercular agents from pyridine derivatives].
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti 2000;49(5):211-20.
2000: Milan Pour; Marcel Spulák; Vojtech Balsánek; Jirí Kunes; Vladimír Buchta; Karel Waisser
3-Phenyl-5-methyl-2H,5H-furan-2-ones: tuning antifungal activity by varying substituents on the phenyl ring.
Bioorganic & medicinal chemistry letters 2000;10(16):1893-5.
2000: Karel Waisser; J Gregor; Lenka Kubicová; Vera Klimesová; Jirí Kunes; Milos Machacek; Jarmila Kaustová
New groups of antimycobacterial agents: 6-chloro-3-phenyl-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 6-chloro-3-phenyl-2H-1,3-benzoxazine-2,4(3H)-dithiones.
European journal of medicinal chemistry 2000;35(7-8):733-41.
2000: Karel Waisser; H Dostál; Lenka Kubicová; K Kolár
[Antitubercular derivatives of quinazoline].
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti 2000;49(3):113-8.
2000: K Nesmĕrák; Martin Pospísek; I Nĕmec; Karel Waisser; Jirí Gabriel
Antifungal properties of substituted 1-phenyl-5-mercaptotetrazoles and their oxidation product, 5-bis-(1-phenyltetrazolyl)disulfide.
Folia microbiologica 2000;45(2):138-42.
1999: Vera Klimesová; M Svoboda; Karel Waisser; Milan Pour; Jarmila Kaustová
New pyridine derivatives as potential antimicrobial agents.
Farmaco (Società chimica italiana : 1989) 1999;54(10):666-72.
1999: Karel Waisser; L Drhová
[Advances in the development of new antitubercular agents from a group of 5-membered heterocyclic compounds containing various heteroatoms].
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti 1999;48(5):195-203.
1999: Karel Waisser; L Drhová
[Advances in the development of new antitubercular agents from a group of 5-membered heterocyclic compounds containing one type of heteroatom].
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti 1999;48(4):147-55.
1998: Karel Waisser; Lenka Kubicová; J Gregor; J Budová; A Andrlová; J Drsata; Z Odlerová
[Relation between chemical structure and antimycobacterial activity against atypical strains. XIII. Thiosalicylanilides].
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti 1998;47(2):84-6.
1998: Karel Waisser; Jirí Kunes; Z Odlerová; M Roman; Lenka Kubicová; V Horák
Antimycobacterial activity of 3'- and 4'-fluorothiobenzanilides.
Die Pharmazie 1998;53(3):193-5.
1998: Karel Waisser; J Hladuvková; J Gregor; T Rada; Lenka Kubicová; Vera Klimesová; Jarmila Kaustová
Relationships between the chemical structure of antimycobacterial substances and their activity against atypical strains. Part 14: 3-Aryl-6,8-dihalogeno-2H-1,3-benzoxazine-2,4(3H)-diones.
Archiv der Pharmazie 1998;331(1):3-6.
1997: Karel Waisser; Rainer Beckert; M Slosáfrek; J Janota
Antimycobacterial activity of some 2,3-dianilinoquinoxaline derivatives.
Die Pharmazie 1997;52(10):797-8.
1997: Lenka Kubicová; Karel Waisser
[Biological effects of substances similar to salicylanilides benzanilides].
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti 1997;46(3):99-107.
1996: Vera Klimesová; M Svoboda; Karel Waisser; Milos Machacek; V Buchta; Z Odlerová
Research on antifungal and antimycobacterial agents. Synthesis and activity of 4-alkylthiopyridine-2-carbothioamides.
Archiv der Pharmazie 1996;329(10):438-42.
1993: Karel Waisser; Lenka Kubicová
[Biological effects of substances similar to salicylanilides. 3-aryl-2H, 4H-benz(e)(1,3)oxazine-2, 4-diones and thiosalicylanilides].
Ceskoslovenská farmacie 1993;42(5):218-22.
1992: Lenka Kubicová; Karel Waisser
[Biological activity of salicylanilides].
Ceskoslovenská farmacie 1992;41(6):208-16.
1990: Karel Waisser
[Use of a logical procedure in searching for a relationship between the chemical structure of substances and their biological activity].
Ceskoslovenská farmacie 1990;39(4):188-91.
1990: Karel Waisser; N Houngbedji; Z Odlerová; W Thiel; R Mayer
[Antitubercular agents. 49. Thiohydrazides, potential antitubercular agents].
Die Pharmazie 1990;45(2):141-2.
1989: Karel Waisser; Z Odlerová; R Beckert; R Mayer
[Comparison of the chemical structure and antimycobacterial action with particular reference to atypical strains. 3. Oxalamidines, a new group of potential antitubercular agents].
Die Pharmazie 1989;44(3):234-5.
1989: Milos Machacek; J Kunes; E Sidóová; Z Odlerová; Karel Waisser
[Relation between the chemical structure of substances and their antimicrobial action against atypical strains. II. 6-acycloamido-2-alkylthiobenzothiazoles, quantitative relation to their effectiveness spectrum].
Ceskoslovenská farmacie 1989;38(1):9-15.
1989: Karel Waisser; Z Odlerová; R Grünert
[Antitubercular agents. 43. A new group of potential antitubercular agents--oxalanilides and malonanilides].
Die Pharmazie 1989;44(2):162-3.
1989: Karel Waisser; Z Odlerová; N Houngbedji; W Thiel; R Mayer
[Antitubercular agents. 45. Antimycobacterial thiohydrazide].
Zentralblatt für Mikrobiologie 1989;144(5):355-7.
1988: Karel Waisser; M Dolezal; E Sidóová; Z Odlerová; J Drsata
[Biological side-effects of potential anti-tubercular agents. XIV. Relation between the chemical structure, antitubercular activity and hepatotoxicity of 2-alkylthio-6-(2-chlorobenzamido) benzothiazoles].
Ceskoslovenská farmacie 1988;37(10):437-9.
1988: Karel Waisser; Z Odlerová; W Thiel; R Mayer
[Antitubercular agents. 44. N,N-dialkyldithiooxamide].
Die Pharmazie 1988;43(11):794.
1988: Karel Waisser; W Thiel; R Mayer; N Houngbedji; J Mlezivová; J Drsata; Z Odlerová
[Antitubercular agents. 42. Dithiooxamides, a new group of potential antitubercular agents].
Die Pharmazie 1988;43(9):655-6.
1988: J Drsata; J Chloupek; Karel Waisser
[Adverse biological effects of potential antitubercular agents. XIII. Use of serum aspartate aminotransferase in the study of organ toxicity of thiobenzamide].
Ceskoslovenská farmacie 1988;37(6):243-5.
1987: Karel Waisser; E Sidóova; Z Odlerova; W Göckeritz; J Drsata
[Relation between chemical structure, antitubercular activity and hepatotoxicity of 2-alkylthio-6-benzamidobenzothiazoles].
Die Pharmazie 1987;42(8):536-7.
1986: J Mollin; Z Odlerová; Karel Waisser
[The relation between antimycobacterial activity and complex formation of various compounds].
Die Pharmazie 1986;41(7):497-8.
1985: J Drsata; J Loskot; R Paulusová; Karel Waisser
[Adverse effects of potential antitubercular agents. 10. Parabolic model of the relation between electronic parameters and hepatotoxicity of thiobenzamide].
Die Pharmazie 1985;40(11):809-10.
1985: J Vanzura; A Hrabálek; Z Odlerová; Karel Waisser; M Celadník
[Antitubercular agents. XXXI. Tetrazole as a potential antitubercular agent].
Ceskoslovenská farmacie 1985;34(7):271-3.
1985: F Bartos; J Findejsová; K el Zein; J Mollin; Karel Waisser
[Biological side-effects of potential antitubercular agents. VIII. Antimitotic activity of thiobenzamides substituted on the nitrogen thioamide function group or on the aromatic cycle in position 2].
Ceskoslovenská farmacie 1985;34(3-4):135-8.
1985: J Drsata; Karel Waisser
[Hepatotoxicity of thiobenzamide in rats].
Casopís lékar̆ů c̆eských 1985;124(6):176-8.
1985: E Sidóová; Z Odlerová; Karel Waisser
[Relation between the chemical structure of substances and their antimycobacterial activity against atypical strains. I. 2-Aklylthio-6-aminobenzothiazol].
Ceskoslovenská farmacie 1985;34(1):7-9.
1984: Karel Waisser; P Beno; J Sova; M Celadník
[Antitubercular agents. XXX. Mechanisms of antitubercular action of ethionamide].
Ceskoslovenská farmacie 1984;33(3-4):99-102.
1983: Karel Waisser; M Celadnik; K Palát; R Karlicek; Z Odlerová; F Bartos; J Drsata
[Quantitative structure-activity analysis of thiobenzamides].
Die Pharmazie 1983;38(12):874-6.
1983: Karel Waisser; H Synková; M Celadník; M Tichý
[Antitubercular agents. XXVII. Physical and physico-chemical characteristics of thiobenzamides. VIII. Solubility of thiobenzamides in water].
Ceskoslovenská farmacie 1983;32(3-4):103-5.
1983: M Celadník; J Vinsová; Vera Klimesová; Karel Waisser; K Palát; Z Odlerová
[Antitubercular agents. XXVIII. Functional derivatives of 4,4' thiodipyridyl-2,2'-dicarboxylic acid and their 1,1-dioxides].
Ceskoslovenská farmacie 1983;32(3-4):97-102.
1983: Karel Waisser; H Synková; M Celadník
[Physical and physico-chemical properties of thiobenzamides. VII. The effect of substituents on hydrophobic properties].
Ceskoslovenská farmacie 1983;32(1):3-5.
1982: Karel Waisser; M Jandejsková; M Celadník
[Agents with antitubercular effects. I. Synthetic substances containing no heterocyclic arrangement in the pharmacophoric group].
Ceskoslovenská farmacie 1982;31(9):353-60.
1982: Karel Waisser; J Loskot; J Drsata
[Biological side-effects of potential antituberculotics. III. Hepatotoxicity of nitrothiobenzamides].
Ceskoslovenská farmacie 1982;31(9):348-50.
1982: Karel Waisser; M Celadník; K Palát; Z Odlerová
[Antitubercular agents. XXVI. The effect of microbiological media used in testing on the evaluation of the structure and antitubercular activity of thiobenzamides].
Ceskoslovenská farmacie 1982;31(8):303-7.
1982: Karel Waisser; P Beno; M Celadník
[Methodologic problems in QSAR. I. Minimal inhibitory concentration as a criterium of antibacterial activity; methodological errors and reciprocal correlations in results on different media].
Ceskoslovenská farmacie 1982;31(1):5-9.
1981: J Drsata; J Loskot; Karel Waisser
[Biological side effects of potential antitubercular agents. I. The relationship between hepatotoxicity and the structure of thiobenzamides].
Ceskoslovenská farmacie 1981;30(8):266-9.
1980: Karel Waisser; M Celadník; K Palát; J Urban
[Antitubercular agents. XXII. Physical and physico-chemical properties of thiobenzamides. III. 13C-NMR spectra].
Ceskoslovenská farmacie 1980;29(10):332-4.
1980: Karel Waisser; R Karlícek; M Celadník; K Palát; Z Odlerová
[Antitubercular agents. XXIV. Physical and physico-chemical properties of thiobenzamides. IV. The ultraviolet spectrum and its relation to antitubercular activity].
Ceskoslovenská farmacie 1980;29(10):339-42.
1980: Karel Waisser; M Celadník; K Palát; Z Odlerová
[Antitubercular agents. XXIII. The effect of testing media on the evaluation of antitubercular activity of thiobenzamides in vitro].
Ceskoslovenská farmacie 1980;29(10):335-8.
1980: J Sova; M Celadník; Karel Waisser; E Kubala; K Palát
[Antitubercular agents. XIX. Functional derivatives of 2-halogen-6-propylisonicotinic acid].
Ceskoslovenská farmacie 1980;29(6):196-20.